Literature DB >> 29557802

Patient and System Characteristics Associated with Performance on the HEDIS Measures of Alcohol and Other Drug Treatment Initiation and Engagement.

Bobbi Jo H Yarborough1, Felicia W Chi, Carla A Green, Agatha Hinman, Jennifer Mertens, Arne Beck, Michael Horberg, Constance Weisner, Cynthia I Campbell.   

Abstract

OBJECTIVES: Understand patient and system characteristics associated with performance on the Healthcare Effectiveness Data and Information Set (HEDIS) Alcohol and Other Drug (AOD) Initiation and Engagement of Treatment (IET) measures.
METHODS: This mixed-methods study linked patient and health system data from four Kaiser Permanente regions to HEDIS performance measure data for 44,320 commercially or Medicare-insured adults with HEDIS-eligible AOD diagnoses in 2012. Characteristics associated with IET were examined using multilevel logistic regression models. Key informant interviews (n = 18) focused on opportunities to improve initiation and engagement.
RESULTS: Non-white race/ethnicity, alcohol abuse, or nonopioid drug abuse diagnoses were associated with lower odds of treatment initiation among commercially insured. For both insurance groups, those diagnosed in healthcare departments other than specialty AOD treatment were less likely to initiate or engage in treatment. Being diagnosed in facilities with co-located AOD/primary care clinics, and those with medications for addiction treatment available, was each associated with higher odds of initiation and engagement for both commercially and Medicare-insured. Having behavioral medicine specialists or clinical health educators in primary care increased initiation and engagement odds among commercially insured. Key informants recommended were as follows: patient-centered care; increased treatment choices; cross-departmental patient identification, engagement, and coordination; provider education; and use of informatics/technology.
CONCLUSIONS: Tailoring treatment, enhancing treatment motivation among individuals with lower severity diagnoses, offering medication treatment of addiction, clinician education, care coordination, co-located AOD and primary care departments, and behavioral medicine specialists in primary care may improve rates of initiation and engagement in AOD treatment.

Entities:  

Mesh:

Year:  2018        PMID: 29557802     DOI: 10.1097/ADM.0000000000000399

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  10 in total

1.  Factors associated with Healthcare Effectiveness Data and Information Set (HEDIS) alcohol and other drug measure performance in 2014-2015.

Authors:  Constance Weisner; Cynthia I Campbell; Andrea Altschuler; Bobbi Jo H Yarborough; Gwen T Lapham; Ingrid A Binswanger; Rulin C Hechter; Brian K Ahmedani; Irina V Haller; Stacy A Sterling; Dennis McCarty; Derek D Satre; Andrea H Kline-Simon
Journal:  Subst Abus       Date:  2019-01-24       Impact factor: 3.716

2.  Predictors of substance use treatment initiation and engagement among adult and adolescent Medicaid recipients.

Authors:  Bonnie K Lind; Dennis McCarty; Yifan Gu; Robin Baker; K John McConnell
Journal:  Subst Abus       Date:  2019-02-13       Impact factor: 3.716

3.  Opioid and Substance Use Disorder and Receipt of Treatment Among Parents Living With Children in the United States, 2015-2017.

Authors:  Lisa Clemans-Cope; Victoria Lynch; Marni Epstein; Genevieve M Kenney
Journal:  Ann Fam Med       Date:  2019-05       Impact factor: 5.166

4.  Clinical Recognition of Substance Use Disorders in Medicaid Primary Care Associated With Universal Screening, Brief Intervention and Referral to Treatment (SBIRT).

Authors:  D. Paul Moberg; Jason Paltzer
Journal:  J Stud Alcohol Drugs       Date:  2021-11       Impact factor: 2.582

5.  Performance Metrics of Substance Use Disorder Care Among Medicaid Enrollees in New York, New York.

Authors:  Margarita Alegría; Irene Falgas-Bague; Marie Fukuda; Jenny Zhen-Duan; Cole Weaver; Isabel O'Malley; Timothy Layton; Jacob Wallace; Lulu Zhang; Sheri Markle; Charles Neighbors; Pat Lincourt; Shazia Hussain; Marc Manseau; Bradley D Stein; Nancy Rigotti; Sarah Wakeman; Martha Kane; A Eden Evins; Thomas McGuire
Journal:  JAMA Health Forum       Date:  2022-07-01

6.  Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings.

Authors:  Andrea H Kline-Simon; Scott P Stumbo; Cynthia I Campbell; Ingrid A Binswanger; Constance Weisner; Irina V Haller; Rulin C Hechter; Brian K Ahmedani; Gwen T Lapham; Amy M Loree; Stacy A Sterling; Bobbi Jo H Yarborough
Journal:  Subst Abus       Date:  2019-01-31       Impact factor: 3.716

7.  Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems.

Authors:  Amy M Loree; Hsueh-Han Yeh; Derek D Satre; Andrea H Kline-Simon; Bobbi Jo H Yarborough; Irina V Haller; Cynthia I Campbell; Gwen T Lapham; Rulin C Hechter; Ingrid A Binswanger; Constance Weisner; Brian K Ahmedani
Journal:  Subst Abus       Date:  2019-01-25       Impact factor: 3.716

8.  Conceptualizing patient-centered care for substance use disorder treatment: findings from a systematic scoping review.

Authors:  Kirsten Marchand; Scott Beaumont; Jordan Westfall; Scott MacDonald; Scott Harrison; David C Marsh; Martin T Schechter; Eugenia Oviedo-Joekes
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-09-11

9.  Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems.

Authors:  Cynthia I Campbell; Constance Weisner; Ingrid A Binswanger; Gwen T Lapham; Brian K Ahmedani; Bobbi Jo H Yarborough; Irina V Haller; Andrea Altschuler; Rulin C Hechter; Amy M Loree; Andrea H Kline-Simon
Journal:  Subst Abus       Date:  2019-01-24       Impact factor: 3.716

10.  Stability in a large drug treatment system: Examining the role of program size and performance on service discontinuation.

Authors:  Erick G Guerrero; Abdullah Alibrahim; Daniel L Howard; Shinyi Wu; Thomas D'Aunno
Journal:  Int J Drug Policy       Date:  2020-09-22
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.